Cure My Disease

Don't miss your cure!

 Log in / Sign up

Seattle tests Short-Stay center to curb opioid overdose deaths

NCT ID NCT06768814

Recruiting now Knowledge-focused Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new center in Seattle where people who have had an opioid overdose can stay for up to 24 hours. The center offers monitoring, medication for opioid use disorder, and connections to ongoing care. Researchers will compare outcomes like repeat overdoses and treatment initiation among those who use the center versus those who don't. The goal is to see if this approach helps prevent future overdoses and improves access to recovery services.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that a short-stay stabilization center after an opioid overdose reduces repeat overdoses and improves access to treatment.
What could go wrong
This is an early-stage observational study, not a controlled trial, so results may not prove cause and effect. The center is only in Seattle, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Harm Reduction opiate dependence Opiate Overdose opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE OPIOID USE DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Downtown Emergency Service Center's Overdose Recovery and Care Access Centers

    RECRUITING

    Seattle, Washington, 98104, United States

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.